Beruflich Dokumente
Kultur Dokumente
v
vi
Dan H. Barouch, MD, PhD John E. Bennett, MD, MACP
Professor of Medicine, Harvard Medical School; Director, Center for Adjunct Professor of Medicine, Uniformed Services University of the
Virology and Vaccine Research, Staff Physician, Beth Israel Deacon- Health Sciences, F. Edward Hebert School of Medicine, Bethesda,
Contributors
Contributors
Departments of Medicine and Microbiology, New York University Human Parvoviruses, Including Parvovirus B19V and Human
School of Medicine, Langone Medical Center, New York, New York Bocaparvoviruses
Introduction to Bacteria and Bacterial Diseases; Campylobacter
jejuni and Related Species; Helicobacter pylori and Other Patricia D. Brown, MD
Gastric Helicobacter Species Professor of Medicine, Department of Internal Medicine, Division of
Infectious Diseases, Wayne State University School of Medicine;
Thomas P. Bleck, MD Corporate Vice President of Quality and Patient Safety, Detroit
Professor of Neurological Sciences, Neurosurgery, Medicine, and Medical Center, Detroit, Michigan
Anesthesiology, Rush Medical College; Associate Chief Medical Infections in Injection Drug Users
Officer (Critical Care), Associate Vice President, Director, Labora-
tory of Electroencephalography and Evoked Potentials, Rush Uni- Barbara A. Brown-Elliott, MS, MT(ASCP)SM
versity Medical Center, Chicago, Illinois Research Assistant Professor, Microbiology, Supervisor, Mycobacteria/
Rabies (Rhabdoviruses); Tetanus (Clostridium tetani); Botulism Nocardia Laboratory, University of Texas Health Science Center,
(Clostridium botulinum) Tyler, Texas
Infections Caused by Nontuberculous Mycobacteria Other than
Nicole M. A. Blijlevens, MD, PhD Mycobacterium avium Complex
Consultant and Lecturer, Department of Haematology, Radboud Uni-
versity Nijmegen Medical Centre, Nijmegen, The Netherlands Roberta L. Bruhn, MS, PhD
Infections in the Immunocompromised Host: General Principles Staff Scientist, Department of Epidemiology, Blood Systems Research
Institute, San Francisco, California
David A. Bobak, MD Human T-Lymphotropic Virus (HTLV)
Associate Professor of Medicine, Associate Chair for Clinical Affairs,
Division of Infectious Diseases and HIV Medicine, Case Western Amy E. Bryant, PhD
Reserve University School of Medicine; Director, Traveler’s Health- Research Career Scientist, Infectious Diseases Section, Veterans Affairs
care Center, Chair, Health System Medication Safety and Therapeu- Medical Center, Boise, Idaho
tics Committee, Staff Physician, Transplant Infectious Diseases Streptococcus pyogenes
Clinic, University Hospitals Case Medical Center, Cleveland, Ohio
Nausea, Vomiting, and Noninflammatory Diarrhea Eileen M. Burd, PhD
Associate Professor, Department of Pathology and Laboratory Medi-
William Bonnez, MD cine, Emory University School of Medicine; Director, Clinical
Professor of Medicine, Department of Medicine, Division of Infectious Microbiology, Emory University Hospital, Atlanta, Georgia
Diseases, University of Rochester School of Medicine and Dentistry, Other Gram-Negative and Gram-Variable Bacilli
Rochester, New York
Papillomaviruses Jane C. Burns, MD
Professor of Pediatrics, University of California San Diego School of
John C. Boothroyd, MD Medicine, La Jolla, California
Professor of Microbiology and Immunology, Stanford University Kawasaki Disease
School of Medicine, Stanford, California
Toxoplasma gondii Larry M. Bush, MD
Affiliated Associate Professor of Medicine, University of Miami Miller
Luciana L. Borio, MD School of Medicine, JFK Medical Center, Palm Beach County,
Assistant Commissioner for Counterterrorism Policy, United States Florida; Affiliated Professor of Medicine, Charles E. Schmidt School
Food and Drug Administration, Silver Spring, Maryland of Medicine, Florida Atlantic University, Boca Raton, Florida
Bioterrorism: An Overview Peritonitis and Intraperitoneal Abscesses
Contributors
School of Health Research, Darwin, Australia Complement and Deficiencies
Burkholderia pseudomallei and Burkholderia mallei: Melioidosis
and Glanders Terence S. Dermody, MD
Dorothy Overall Wells Professor of Pediatrics, Director, Division of
Erika D’Agata, MD, MPH Infectious Diseases, Director, Elizabeth B. Lamb Center for Pediatric
Associate Professor of Medicine, Brown University; Department of Research, Director, Vanderbilt Medical Scientist Training Program,
Medicine, Division of Infectious Diseases, Rhode Island Hospital, Vanderbilt University School of Medicine, Nashville, Tennessee
Providence, Rhode Island Biology of Viruses and Viral Diseases
Pseudomonas aeruginosa and Other Pseudomonas Species
Robin Dewar, PhD
Inger K. Damon, MD, PhD Principal Scientist, Leidos Biomedical Research—Frederick, National
Adjunct Clinical Faculty, Department of Medicine, Emory University Cancer Institute—Frederick, Frederick, Maryland
School of Medicine; Director, Division of High-Consequence Patho- Diagnosis of Human Immunodeficiency Virus Infection
gens and Pathology, Centers for Disease Control and Prevention,
Atlanta, Georgia James H. Diaz, MD, MPHTM, DrPH
Orthopoxviruses: Vaccinia (Smallpox Vaccine), Variola (Smallpox), Professor of Public Health and Preventive Medicine, School of Public
Monkeypox, and Cowpox; Other Poxviruses That Infect Humans: Health, Louisiana State University Health Sciences Center, New
Parapoxviruses (Including Orf Virus), Molluscum Contagiosum, Orleans, Louisiana
and Yatapoxviruses Introduction to Ectoparasitic Diseases; Lice (Pediculosis); Scabies;
Myiasis and Tungiasis; Mites, Including Chiggers; Ticks, Includ-
Rabih O. Darouiche, MD ing Tick Paralysis
VA Distinguished Service Professor, Departments of Medicine, Surgery,
and Physical Medicine and Rehabilitation, Michael E. DeBakey VA Carl W. Dieffenbach, PhD
Medical Center and Baylor College of Medicine, Houston, Texas Director, Division of AIDS, National Institute of Allergy and Infectious
Infections in Patients with Spinal Cord Injury Diseases, National Institutes of Health, Bethesda, Maryland
Innate (General or Nonspecific) Host Defense Mechanisms
Roberta L. DeBiasi, MD
Acting Chief, Division of Pediatric Infectious Diseases, Children’s Jules L. Dienstag, MD
National Medical Center; Professor of Pediatrics and Microbiology, Dean for Medical Education, Carl W. Walter Professor of Medicine,
Immunology and Tropical Medicine, George Washington University Harvard Medical School; Physician, Massachusetts General Hospi-
School of Medicine; Principal Investigator, Center for Clinical and tal, Boston, Massachusetts
Translational Science, Children’s Research Institute, Washington, DC Antiviral Drugs against Hepatitis Viruses; Viral Hepatitis
Orthoreoviruses and Orbiviruses; Coltiviruses and
Seadornaviruses Yohei Doi, MD, PhD
Assistant Professor of Medicine, Division of Infectious Diseases, Uni-
George S. Deepe, Jr., MD versity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Professor, Department of Internal Medicine, Division of Infectious Penicillins and β-Lactamase Inhibitors; Other β-Lactam Antibiotics
Diseases, University of Cincinnati College of Medicine, Cincinnati,
Ohio Raphael Dolin, MD
Histoplasma capsulatum (Histoplasmosis) Maxwell Finland Professor of Medicine (Microbiology and Molecular
Genetics), Harvard Medical School; Attending Physician, Beth Israel
Carlos del Rio, MD Deaconess Medical Center; Brigham and Women’s Hospital, Boston,
Professor and Chair, Hubert Department of Global Health, Rollins Massachusetts
School of Public Health, Emory University; Co-Director, Emory Antiviral Agents: General Principles; Miscellaneous Antiviral
Center for AIDS Research, Atlanta, Georgia Agents (Interferons, Imiquimod, Pleconaril); Vaccines for Human
Epidemiology and Prevention of Acquired Immunodeficiency Syn- Immunodeficiency Virus Type 1 Infection; Zoonotic Paramyxo-
drome and Human Immunodeficiency Virus Infection viruses: Nipah, Hendra, and Menangle; Noroviruses and Sapo-
viruses (Caliciviruses); Astroviruses and Picobirnaviruses
Andrew S. Delemos, MD
Transplant Hepatologist, Carolinas Healthcare System, Charlotte, J. Peter Donnelly, PhD
North Carolina Coordinator of Studies in Supportive Care, Department of Hae
Viral Hepatitis matology, Radboud University Nijmegen Medical Centre, Nijme-
gen, The Netherlands
Frank R. DeLeo, PhD Infections in the Immunocompromised Host: General Principles
Chief, Pathogen-Host Cell Biology Section, Laboratory of Human Bac-
terial Pathogenesis, National Institute of Allergy and Infectious Dis- Michael S. Donnenberg, MD
eases, National Institutes of Health, Bethesda, Maryland Professor of Medicine, Microbiology, and Immunology, University of
Granulocytic Phagocytes Maryland School of Medicine, Baltimore, Maryland
Enterobacteriaceae
Gregory P. DeMuri, MD
Associate Professor, University of Wisconsin School of Medicine and Gerald R. Donowitz, MD
Public Health; Attending Physician, American Family Children’s Professor of Medicine and Infectious Diseases/International Health,
Hospital, Madison, Wisconsin Department of Medicine, University of Virginia, Charlottesville,
Sinusitis Virginia
Linezolid and Other Oxazolidinones; Acute Pneumonia
x
Philip R. Dormitzer, MD, PhD Morven S. Edwards, MD
Head of U.S. Research, Global Head of Virology, Vice President, Professor of Pediatrics, Baylor College of Medicine; Attending Physi-
Novartis Vaccines, Cambridge, Massachusetts cian, Department of Pediatrics, Infectious Diseases Section, Texas
Contributors
Contributors
tute of Allergy and Infectious Diseases, Bethesda, Maryland Maryland
The Immunology of Human Immunodeficiency Virus Infection Human Immunodeficiency Viruses
†
Deceased.
xiii
Kevin P. High, MD, MS Harold W. Horowitz, MD
Professor of Medicine and Chief, Section on Infectious Diseases, Professor of Medicine, Infectious Diseases and Immunology, Depart-
Department of Internal Medicine, Wake Forest School of Medicine, ment of Medicine, New York University School of Medicine; Chief
Contributors
Winston-Salem, North Carolina of Service Infectious Diseases, Bellevue Hospital Center, New York,
Nutrition, Immunity, and Infection New York
Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Adrian V. S. Hill, DPhil, DM
Professor of Human Genetics, Wellcome Trust Centre for Human C. Robert Horsburgh, Jr., MD, MUS
Genetics, University of Oxford, Oxford, United Kingdom Professor of Epidemiology, Biostatistics, and Medicine, Boston Univer-
Human Genetics and Infection sity Schools of Public Health and Medicine, Boston, Massachusetts
Mycobacterium avium Complex
David R. Hill, MD, DTM&H
Professor, Department of Medical Sciences, Director, Global Public James M. Horton, MD
Health, Frank H. Netter MD School of Medicine, Quinnipiac Uni- Chief, Division of Infectious Diseases, Department of Internal Medi-
versity, Hamden, Connecticut cine, Carolinas Medical Center, Charlotte, North Carolina
Giardia lamblia Urinary Tract Agents: Nitrofurantoin, Fosfomycin, and Methena-
mine; Relapsing Fever Caused by Borrelia Species
Alan R. Hinman, MD, MPH
Center for Vaccine Equity, Task Force for Global Health, Decatur, Duane R. Hospenthal, MD, PhD
Georgia Adjunct Professor of Medicine, Department of Medicine, Infectious
Immunization Disease Division, University of Texas Health Science Center at San
Antonio, San Antonio, Texas
Martin S. Hirsch, MD Agents of Chromoblastomycosis; Agents of Mycetoma; Uncom-
Professor of Medicine, Harvard Medical School; Professor of Infectious mon Fungi and Related Species
Diseases and Immunology, Harvard School of Public Health; Senior
Physician, Infectious Diseases Service, Massachusetts General Hos- Kevin Hsueh, MD
pital, Boston, Massachusetts Infectious Diseases Fellow, NYU Langone Medical Center, New York,
Antiretroviral Therapy for Human Immunodeficiency Virus New York
Infection Outpatient Parenteral Antimicrobial Therapy
Aurora, Colorado; Director, Mucosal and Vaccine Research Center, cine and Pediatrics, University of Texas Southwestern Medical
Denver Veterans Affairs Medical Center, Denver, Colorado Center, Dallas, Texas
Streptococcus pneumoniae Antibiotic Allergy
Contributors
Bacilli General Hospital, Boston, Massachusetts
Syndromes of Enteric Infection
Dimitrios P. Kontoyiannis, MD
Frances King Black Endowed Professor, Department of Infectious Dis- James E. Leggett, MD
eases, Deputy Head, Division of Internal Medicine, University of Associate Professor of Medicine, Oregon Health and Science Univer-
Texas MD Anderson Cancer Center, Houston, Texas sity; Infectious Diseases Consultant, Medical Education, Providence
Agents of Mucormycosis and Entomophthoramycosis Portland Medical Center, Portland, Oregon
Aminoglycosides
Igor J. Koralnik, MD
Professor of Neurology, Harvard Medical School; Chief, Division of Helena Legido-Quigley, MSc, PhD
Neuro-Virology, Director, HIV/Neurology Center, Beth Israel Dea- Lecturer in Global Health, London School of Hygiene and Tropical
coness Medical Center, Boston, Massachusetts Medicine, London, United Kingdom
Neurologic Diseases Caused by Human Immunodeficiency Virus Global Perspectives on Human Immunodeficiency Virus Infection
Type 1 and Opportunistic Infections; JC, BK, and Other Polyoma- and Acquired Immunodeficiency Syndrome
viruses: Progressive Multifocal Leukoencephalopathy (PML)
Paul N. Levett, PhD, DSc
Poonum S. Korpe, MD Assistant Clinical Director, Saskatchewan Disease Control Laboratory,
Infectious Diseases Fellow, University of Virginia School of Medicine, Regina, Saskatchewan, Canada
Charlottesville, Virginia Leptospira Species (Leptospirosis)
Introduction to Protozoal Diseases
Donald P. Levine, MD
Anita A. Koshy, MD Professor of Medicine, Associate Vice Chair for Continuing Medical
Assistant Professor, Departments of Neurology and Immunobiology, Education and Community Affairs, Department of Medicine, Wayne
University of Arizona, Tucson, Arizona State University, Detroit, Michigan
Free-Living Amebae Infections in Injection Drug Users
Contributors
Hospital, Akron, Ohio Interim Director, Children’s Hospital at Dartmouth, Lebanon, New
Croup in Children (Acute Laryngotracheobronchitis); Bronchiolitis Hampshire
Introduction to the Human Enteroviruses and Parechoviruses;
James S. McCarthy, MD Poliovirus; Coxsackieviruses, Echoviruses, and Numbered
Professor of Medicine, Division of Infectious Diseases, Royal Brisbane Enteroviruses; Human Parechoviruses
and Women’s Hospital; Professor of Medicine, Department of Infec-
tious Diseases, Queensland Institute of Medical Research, University Rajal K. Mody, MD, MPH
of Queensland, Brisbane, Australia Lead, National Surveillance Team, Enteric Diseases Epidemiology
Antimalarial Drugs; Drugs for Protozoal Infections Other Than Branch, Division of Foodborne, Waterborne, and Environmental
Malaria; Drugs for Helminths Diseases, National Center for Emerging and Zoonotic Diseases,
Centers for Disease Control and Prevention, Atlanta, Georgia
William M. McCormack, MD Foodborne Disease
Distinguished Teaching Professor of Medicine and of Obstetrics and
Gynecology, Emeritus, Division of Infectious Diseases, Department Robert C. Moellering, Jr., MD†
of Medicine, SUNY Downstate Medical Center, Brooklyn, New York Shields Warren-Mallinckrodt Professor of Medical Research, Harvard
Urethritis; Vulvovaginitis and Cervicitis Medical School; Physician, Division of Infectious Diseases, Beth
Israel Deaconess Medical Center, Boston, Massachusetts
Catherine C. McGowan, MD Principles of Anti-infective Therapy
Associate Professor, Department of Medicine, Division of Infectious
Diseases, Vanderbilt University School of Medicine, Nashville, Matthew Moffa, DO
Tennessee Physician, Infectious Diseases and Travel Medicine, Georgetown Uni-
Prostatitis, Epididymitis, and Orchitis versity Hospital, Washington, DC
Tetracyclines, Glycylcyclines, and Chloramphenicol
Kenneth McIntosh, MD
Professor of Pediatrics, Harvard Medical School; Senior Physician, Susan Moir, PhD
Department of Medicine, Children’s Hospital, Boston, Laboratory of Immunoregulation, National Institute of Allergy and
Massachusetts Infectious Diseases, Bethesda, Maryland
Coronaviruses, Including Severe Acute Respiratory Syndrome The Immunology of Human Immunodeficiency Virus Infection
(SARS) and Middle East Respiratory Syndrome (MERS)
José G. Montoya, MD
Paul S. Mead, MD, MPH Professor of Medicine, Division of Infectious Diseases and Geographic
Chief, Epidemiology and Surveillance Activity, Bacterial Disease Medicine, Stanford University School of Medicine, Stanford,
Branch, National Center for Zoonotic, Vector-Borne, and Enteric California
Diseases, Centers for Disease Control and Prevention, Fort Collins, Toxoplasma gondii
Colorado
Yersinia Species (Including Plague) Thomas A. Moore, MD
Clinical Professor of Medicine, University of Kansas School of Medi-
Malgorzata Mikulska, MD cine at Wichita, Wichita, Kansas
Division of Infectious Diseases, IRCCS AOU San Martino-IST; Depart- Drugs for Helminths
ment of Health Sciences, University of Genova, Genova, Italy
Prophylaxis and Empirical Therapy of Infection in Cancer Patients Philippe Moreillon, MD, PhD
Professor and Vice Rector for Research, Department of Fundamental
Robert F. Miller, MBBS Microbiology, University of Lausanne, Lausanne, Switzerland
Reader in Clinical Infection, Honorary Professor, London School of Staphylococcus aureus (Including Staphylococcal Toxic Shock
Hygiene and Tropical Medicine; Honorary Consultant Physician, Syndrome)
Camden Provider Services, Central and North West London NHS
Foundation Trust, and at University College London Hospitals, Uni- J. Glenn Morris, Jr., MD, MPH&TM
versity College London, London, United Kingdom Director, Emerging Pathogens Institute, University of Florida; Profes-
Pneumocystis Species sor of Medicine, Division of Infectious Diseases. University of
Florida College of Medicine, Gainesville, Florida
Samuel I. Miller, MD Human Illness Associated with Harmful Algal Blooms
Professor of Medicine, Microbiology, Genome Sciences, and Immunol-
ogy, Department of Immunology, University of Washington School Caryn Gee Morse, MD, MPH
of Medicine, Seattle, Washington Assistant Clinical Investigator, Critical Care Medicine Department,
Salmonella Species HIV/AIDS Section, National Institutes of Health Clinical Center,
Bethesda, Maryland
David H. Mitchell, MBBS Nutrition, Immunity, and Infection
Clinical Senior Lecturer, University of Sydney Faculty of Medicine,
Sydney, New South Wales, Australia; Senior Staff Specialist, Centre Robin Moseley, MAT
for Infectious Diseases and Microbiology, Westmead Hospital, Public Health Advisor, Office of Infectious Diseases, Centers for
Westmead, New South Wales, Australia Disease Control and Prevention, Atlanta, Georgia
Nocardia Species Emerging and Reemerging Infectious Disease Threats
†
Deceased.
xviii
Robert S. Munford, MD Theodore E. Nash, MD
Senior Clinician, Laboratory of Clinical Infectious Diseases, National Head, Gastrointestinal Parasites Section, Laboratory of Parasitic Dis-
Institute of Allergy and Infectious Diseases, National Institutes of eases, National Institute of Allergy and Infectious Diseases, National
Contributors
Contributors
Osteomyelitis Health Care System, San Antonio, Texas
Aspergillus Species
Michael T. Osterholm, PhD, MPH
Professor, Division of Environmental Health Sciences, University of Deborah Pavan-Langston, MD
Minnesota School of Public Health; Adjunct Professor, University of Professor, Department of Ophthalmology, Harvard Medical School;
Minnesota Medical School, Minneapolis, Minnesota Attending Physician, Massachusetts Eye and Ear Infirmary, Boston,
Epidemiologic Principles Massachusetts
Microbial Conjunctivitis; Microbial Keratitis
Stephen M. Ostroff, MD
Chief Science Officer (Acting), Office of the Chief Scientist, U.S. Food David A. Pegues, MD
and Drug Administration, Silver Spring, Maryland Professor of Medicine, Division of Infectious Diseases, Perelman
Emerging and Reemerging Infectious Disease Threats School of Medicine at the University of Pennsylvania; Medical
Director, Healthcare Epidemiology, Infection Prevention and
Michael N. Oxman, MD Control; Antimicrobial Management Program, Hospital of the Uni-
Professor of Medicine and Pathology, University of California San versity of Pennsylvania, Philadelphia, Pennsylvania
Diego School of Medicine, La Jolla, California; Staff Physician, Infec- Salmonella Species
tious Diseases, Veterans Affairs San Diego Healthcare System, San
Diego, California Robert L. Penn, MD
Myocarditis and Pericarditis Professor of Medicine, Infectious Diseases Section, Louisiana State
University School of Medicine in Shreveport; Physician, Infectious
Slobodan Paessler, DVM, PhD Diseases Section, Overton Brooks Veterans Affairs Medical Center,
Professor, Department of Pathology, Director, Preclinical Studies Core, Shreveport, Louisiana
Director, Animal Biosafety Level 3, Galveston National Laboratory, Francisella tularensis (Tularemia)
Institute for Human Infections and Immunity, University of Texas
Medical Branch, Galveston, Texas John R. Perfect, MD
Lymphocytic Choriomeningitis, Lassa Fever, and the South Ameri- James B. Duke Professor of Medicine, Chief, Infectious Diseases,
can Hemorrhagic Fevers (Arenaviruses) Department of Medicine, Duke University Medical Center, Durham,
North Carolina
Andrea V. Page, MD, MSc Cryptococcosis (Cryptococcus neoformans and Cryptococcus
Assistant Professor, Department of Medicine, University of Toronto; gattii)
Staff Physician, Division of Infectious Diseases, Mount Sinai Hospi-
tal, Toronto, Ontario, Canada Stanley Perlman, MD, PhD
Immunomodulators Professor, Department of Microbiology and Pediatrics, University of
Iowa Carver College of Medicine, Iowa City, Iowa
Manjunath P. Pai, PharmD Coronaviruses, Including Severe Acute Respiratory Syndrome
Associate Professor, Department of Pharmacy Practice, Albany College (SARS) and Middle East Respiratory Syndrome (MERS)
of Pharmacy and Health Sciences, Albany, New York
Pharmacokinetics and Pharmacodynamics of Anti-infective Brett W. Petersen, MD, MPH
Agents; Tables of Anti-infective Agent Pharmacology Medical Officer, Poxvirus and Rabies Branch, Division of High-
Consequence Pathogens and Pathology, Centers for Disease Control
Tara N. Palmore, MD and Prevention, Atlanta, Georgia
Epidemiologist, National Institutes of Health Clinical Center; Attend- Orthopoxviruses: Vaccinia (Smallpox Vaccine), Variola (Smallpox),
ing Physician, Infectious Diseases Consultation Service, Program Monkeypox, and Cowpox; Other Poxviruses That Infect Humans:
Director, Infectious Diseases Training Program, National Institute Parapoxviruses (Including Orf Virus), Molluscum Contagiosum,
of Allergy and Infectious Diseases/National Institutes of Health, and Yatapoxviruses
Bethesda, Maryland
Nosocomial Herpesvirus Infections Phillip K. Peterson, MD
Professor of Medicine, Director, International Medical Education and
Raj Palraj, MBBS Research, University of Minnesota Medical School, Minneapolis,
Instructor of Medicine, Mayo Clinic College of Medicine; Senior Minnesota
Associate Consultant, Infectious Diseases, Mayo Clinic, Rochester, Infections in the Elderly
Minnesota
Prosthetic Valve Endocarditis William A. Petri, Jr., MD, PhD
Wade Hampton Frost Professor of Epidemiology, University of Vir-
Peter G. Pappas, MD ginia; Chief, Division of Infectious Disease and International Health,
Professor of Medicine, Division of Infectious Diseases, University of University of Virginia Health System, Charlottesville, Virginia
Alabama at Birmingham, Birmingham, Alabama Introduction to Protozoal Diseases; Entamoeba Species, Including
Chronic Pneumonia Amebic Colitis and Liver Abscess
Contributors
and Reemerging Pathogens, University of Texas Medical School, Hill School of Medicine; Director, Hospital Epidemiology, Occupa-
Houston, Texas; Head of Infection, Global Medicines Development, tional Health and Safety, University of North Carolina Health Care,
AstraZeneca Pharmaceuticals, Waltham, Massachusetts Chapel Hill, North Carolina
Drugs Active against Fungi, Pneumocystis, and Microsporidia; The Acutely Ill Patient with Fever and Rash; Disinfection, Steriliza-
Sporothrix schenckii tion, and Control of Hospital Waste
Clinical Research Division, Fred Hutchinson Cancer Research Infectious Diseases, Department of Pediatrics, Ann & Robert H.
Center, Seattle, Washington Lurie Children’s Hospital of Chicago, Chicago, Illinois
Herpes Simplex Virus Nonsuppurative Poststreptococcal Sequelae: Rheumatic Fever and
Glomerulonephritis
David Schlossberg, MD
Professor, Department of Medicine, Temple University School of Med- George K. Siberry, MD, MPH
icine; Medical Director, Tuberculosis Control Program, Philadelphia Medical Officer, Maternal and Pediatric Infectious Disease Branch,
Department of Public Health, Philadelphia, Pennsylvania Eunice Kennedy Shriver National Institute of Child Health and
Psittacosis (Due to Chlamydia psittaci) Human Development, National Institutes of Health, Bethesda,
Maryland
Thomas Schneider, MD, PhD Pediatric Human Immunodeficiency Virus Infection
Professor of Infectious Diseases, Charité University Hospital, Benja-
min Franklin Campus, Berlin, Germany Omar K. Siddiqi, MD
Whipple’s Disease Clinical Instructor, Department of Neurology, Beth Israel Deaconess
Medical Center, Boston, Massachusetts; Honorary Lecturer, Depart-
Anne Schuchat, MD (RADM USPHS) ment Medicine, University of Zambia School of Medicine, Lusaka,
Assistant Surgeon General, United States Public Health Service; Direc- Zambia
tor, National Center for Immunization and Respiratory Diseases, Neurologic Diseases Caused by Human Immunodeficiency Virus
Centers for Disease Control and Prevention, Atlanta, Georgia Type 1 and Opportunistic Infections
Emerging and Reemerging Infectious Disease Threats
Costi D. Sifri, MD
Jane R. Schwebke, MD Associate Professor of Medicine, Division of Infectious Diseases and
Professor of Medicine, Medicine/Infectious Diseases, University of International Health, University of Virginia School of Medicine;
Alabama at Birmingham, Birmingham, Alabama Attending Physician, Department of Medicine, University of Vir-
Trichomonas vaginalis ginia Health System, Charlottesville, Virginia
Infections of the Liver and Biliary System (Liver Abscess, Cholan-
Cynthia L. Sears, MD gitis, Cholecystitis); Appendicitis; Diverticulitis and Typhlitis
Professor of Medicine, Divisions of Infectious Diseases and Gastroen-
terology, Johns Hopkins University School of Medicine, Baltimore, Michael S. Simberkoff, MD
Maryland Professor of Medicine, Department of Medicine, Division of Infectious
Prebiotics, Probiotics, and Synbiotics Diseases and Immunology, New York University School of Medi-
cine, New York, New York
Leopoldo N. Segal, MD Mycoplasma pneumoniae and Atypical Pneumonia
Assistant Professor, Department of Medicine, New York University
School of Medicine, New York, New York Francesco R. Simonetti, MD
Acute Exacerbations of Chronic Obstructive Pulmonary Disease Guest Researcher, HIV Drug Resistance Program, National Cancer
Institute—Frederick, National Institutes of Health, Frederick,
Parham Sendi, MD Maryland
Consultant and Lecturer, Basel University Medical Clinic, Liestal, Swit- Diagnosis of Human Immunodeficiency Virus Infection
zerland; Department of Infectious Diseases, University Hospital
and Institute for Infectious Diseases, University of Bern, Bern, Kamaljit Singh, MD, D(ABMM)
Switzerland Associate Professor, Departments of Medicine and Pathology, Rush
Orthopedic Implant–Associated Infections University Medical Center, Chicago, Illinois
Rabies (Rhabdoviruses)
Kent A. Sepkowitz, MD
Deputy Physician-in-Chief, Quality and Safety, Memorial Sloan Ket- Nina Singh, MD
tering Cancer Center; Professor of Medicine, Weill Cornell Medical Professor of Medicine, Department of Medicine, Division of Infectious
College, New York, New York Diseases, University of Pittsburgh and VA Pittsburgh Healthcare
Health Care–Acquired Hepatitis System, Pittsburgh, Pennsylvania
Infections in Solid-Organ Transplant Recipients
Edward J. Septimus, MD
Clinical Professor, Department of Internal Medicine, Texas A&M Upinder Singh, MD
Health Science Center, Houston, Texas; Medical Director, Infection Associate Professor of Medicine, Departments of Infectious Diseases
Prevention and Epidemiology, Clinical Services Group, HCA, Inc., and Microbiology & Immunology, Stanford School of Medicine,
Nashville, Tennessee Stanford, California
Pleural Effusion and Empyema Free-Living Amebae
Contributors
Oklahoma General Clinical Manifestations of Human Immunodeficiency
Bartonella, Including Cat-Scratch Disease Virus Infection (Including Acute Retroviral Syndrome and Oral,
Cutaneous, Renal, Ocular, Metabolic, and Cardiac Diseases);
A. George Smulian, MB BCh, MSc Mycobacterium tuberculosis
Associate Professor, University of Cincinnati College of Medicine;
Chief, Infectious Disease Section, Veterans Affairs Cincinnati David A. Stevens, MD
Medical Center, Cincinnati, Ohio Professor of Medicine, Stanford University, Stanford, California; Hos-
Pneumocystis Species pital Epidemiologist, Santa Clara Valley Medical Center; President,
California Institute for Medical Research; Principal Investigator,
Jack D. Sobel, MD Infectious Diseases Research Laboratory, California Institute for
Professor of Medicine, Division of Infectious Diseases, Wayne State Medical Research, San Jose, California
University School of Medicine, Detroit, Michigan Drugs Active against Fungi, Pneumocystis, and Microsporidia
Urinary Tract Infections
Dennis L. Stevens, MD, PhD
M. Rizwan Sohail, MD Associate Chief of Staff, Research and Development Service, Veterans
Associate Professor of Medicine, Divisions of Infectious Diseases and Affairs Medical Center, Boise, Idaho; Professor of Medicine Depart-
Cardiovascular Diseases, Department of Medicine, Mayo Clinic ment of Medicine, University of Washington, Seattle, Washington
College of Medicine, Rochester, Minnesota Streptococcus pyogenes
Infections of Nonvalvular Cardiovascular Devices
Jacob Strahilevitz, MD
David E. Soper, MD Senior Lecturer in Clinical Microbiology, Hebrew University; Attend-
Professor and Vice Chairman, Department of Obstetrics and Gynecol- ing Physician, Clinical Microbiology and Infectious Diseases,
ogy, Medical University of South Carolina, Charleston, South Hadassah Medical Center, Jerusalem, Israel
Carolina Quinolones
Infections of the Female Pelvis
Charles W. Stratton IV, MD
Tania C. Sorrell, AM, MD, MBBS Associate Professor of Pathology and Medicine, Vanderbilt University
Professor and Director, Marie Bashir Institute for Infectious Diseases School of Medicine; Director, Clinical Microbiology Laboratory,
and Biosecurity, University of Sydney, Sydney, New South Wales, Vanderbilt University Medical Center, Nashville, Tennessee
Australia; Director, Centre for Infectious Diseases and Microbiology Streptococcus anginosus Group
and Service Director, Infectious Diseases and Sexual Health, West-
mead, New South Wales, Australia Anthony F. Suffredini, MD
Nocardia Species Senior Investigator, Critical Care Medicine Department, Clinical
Center, National Institutes of Health, Bethesda, Maryland
James M. Steckelberg, MD Sepsis, Severe Sepsis, and Septic Shock
Professor of Medicine, Consultant, Division of Infectious Diseases,
Mayo Clinic, Rochester, Minnesota Kathryn N. Suh, MD, MSc
Osteomyelitis Associate Professor of Medicine, University of Ottawa; Division of
Infectious Diseases, The Ottawa Hospital, Ottawa, Canada
Allen C. Steere, MD Cyclospora cayetanensis, Cystoisospora (Isospora) belli, Sarcocystis
Professor of Medicine, Harvard Medical School, Harvard University; Species, Balantidium coli, and Blastocystis Species
Director, Translational Research in Rheumatology, Massachusetts
General Hospital, Boston, Massachusetts Mark S. Sulkowski, MD
Lyme Disease (Lyme Borreliosis) Due to Borrelia burgdorferi Professor of Medicine, Medical Director, Viral Hepatitis Center Divi-
sions of Infectious Diseases and Gastroenterology/Hepatology,
Neal H. Steigbigel, MD Johns Hopkins University School of Medicine, Baltimore,
Professor of Medicine, Division of Infectious Diseases and Immunol- Maryland
ogy, New York University School of Medicine; Staff Physician, Gastrointestinal, Hepatobiliary, and Pancreatic Manifestations of
Medical Service, Infectious Diseases Section, New York Veterans Human Immunodeficiency Virus Infection
Affairs Medical Center, New York, New York
Macrolides, Clindamycin, and Ketolides Morton N. Swartz, MD†
Associate Firm Chief, Infectious Diseases Unit, Massachusetts General
James P. Steinberg, MD Hospital, Boston, Massachusetts
Professor of Medicine, Division of Infectious Diseases, Emory Univer- Cellulitis, Necrotizing Fasciitis, and Subcutaneous Tissue Infec-
sity School of Medicine; Chief Medical Officer, Emory University tions; Myositis and Myonecrosis; Lymphadenitis and
Hospital Midtown, Atlanta, Georgia Lymphangitis
Other Gram-Negative and Gram-Variable Bacilli
Thomas R. Talbot, MD, MPH
David S. Stephens, MD Associate Professor of Medicine and Health Policy, Vanderbilt Univer-
Stephen W. Schwarzmann Distinguished Professor of Medicine, Chair, sity School of Medicine; Chief Hospital Epidemiologist, Vanderbilt
Department of Medicine, Emory University School of Medicine; University Medical Center, Nashville, Tennessee
Vice President for Research, Robert W. Woodruff Health Sciences Surgical Site Infections and Antimicrobial Prophylaxis
Center, Emory University, Atlanta, Georgia
Neisseria meningitidis
†
Deceased.
xxiv
C. Sabrina Tan, MD Athe M. N. Tsibris, MD, MS
Assistant Professor of Medicine, Harvard Medical School, Beth Israel Assistant Professor in Medicine, Division of Infectious Diseases,
Deaconess Medical Center, Boston, Massachusetts Harvard Medical School; Brigham and Women’s Hospital, Boston,
Contributors
Claudio Viscoli, MD
Division of Infectious Diseases, IRCCS AOU San Martino-IST; Depart-
ment of Health Sciences, University of Genova, Genova, Italy
Prophylaxis and Empirical Therapy of Infection in Cancer Patients
xxv
Ellen R. Wald, MD David J. Weber, MD, MPH
Alfred Dorrance Daniels Professor on Diseases of Children, University Professor of Medicine, Pediatrics, and Epidemiology, University of
of Wisconsin School of Medicine and Public Health; Pediatrician-in- North Carolina at Chapel Hill School of Medicine; Associate Chief
Contributors
Chief, American Family Children’s Hospital, Madison, Wisconsin of Staff and Medical Director, Hospital Epidemiology and Occupa-
Sinusitis tional Health, University of North Carolina Health Care, Chapel
Hill, North Carolina
Matthew K. Waldor, MD, PhD The Acutely Ill Patient with Fever and Rash; Disinfection, Steriliza-
Edward H. Kass Professor of Medicine, Harvard Medical School; Divi- tion, and Control of Hospital Waste
sion of Infectious Diseases, Brigham and Women’s Hospital, Boston,
Massachusetts Michael D. Weiden, MD
Vibrio cholerae Associate Professor, Departments of Medicine and Environmental
Medicine, New York University School of Medicine, Langone
David H. Walker, MD Medical Center, New York, New York
Professor, Department of Pathology, University of Texas Medical Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Branch; Executive Director, Center for Biodefense and Emerging
Infectious Diseases, Galveston, Texas Geoffrey A. Weinberg, MD
Rickettsia rickettsii and Other Spotted Fever Group Rickettsiae Professor of Pediatrics, Department of Pediatrics, University of Roch-
(Rocky Mountain Spotted Fever and Other Spotted Fevers); ester School of Medicine and Dentistry; Director, Pediatric HIV
Rickettsia prowazekii (Epidemic or Louse-Borne Typhus); Program, Golisano Children’s Hospital, University of Rochester
Rickettsia typhi (Murine Typhus); Ehrlichia chaffeensis Medical Center, Rochester, New York
(Human Monocytotropic Ehrlichiosis), Anaplasma phagocyto- Epiglottitis; Pediatric Human Immunodeficiency Virus Infection
philum (Human Granulocytotropic Anaplasmosis), and Other
Anaplasmataceae Daniel J. Weisdorf, MD
Professor of Medicine, Division of Hematology, Oncology, and
Richard J. Wallace, Jr., MD Transplantation, Director, Adult Blood and Marrow Transplant
Chairman, Department of Microbiology, University of Texas Health Program, University of Minnesota Medical School, Minneapolis,
Northeast, Tyler, Texas Minnesota
Antimycobacterial Agents; Infections Caused by Nontuberculous Infections in Recipients of Hematopoietic Stem Cell Transplants
Mycobacteria Other than Mycobacterium avium Complex
Louis M. Weiss, MD, MPH
Edward E. Walsh, MD Professor, Departments of Pathology and Medicine, Albert Einstein
Professor of Medicine, Department of Infectious Diseases, University College of Medicine, Bronx, New York
of Rochester School of Medicine and Dentistry, Rochester, New York Microsporidiosis
Acute Bronchitis; Respiratory Syncytial Virus (RSV)
David F. Welch, PhD
Stephen R. Walsh, MD Clinical Consultant, Medical Microbiology Consulting, LLC, Dallas,
Assistant Professor of Medicine, Harvard Medical School; Beth Israel Texas
Deaconess Medical Center, Boston, Massachusetts Bartonella, Including Cat-Scratch Disease
Hepatitis E Virus
Thomas E. Wellems, MD, PhD
Peter D. Walzer, MD, MSc Chief, Laboratory of Malaria and Vector Research, Chief, Malaria
Emeritus Professor of Medicine, University of Cincinnati; Retired Genetics Section, Laboratory of Malaria and Vector Research,
Associate Chief of Staff for Research, Cincinnati VA Medical Center, National Institute of Allergy and Infectious Diseases, Rockville,
Cincinnati, Ohio Maryland
Pneumocystis Species Malaria (Plasmodium Species)
Clinic, Rochester, Minnesota University of Michigan Medical School, Ann Arbor, Michigan
Prosthetic Valve Endocarditis; Infections of Nonvalvular Cardio- Clostridium difficile Infection
vascular Devices
Nadezhda Yun, MD
Glenn W. Wortmann, MD Assistant Professor, Department of Pathology, Assistant Director, Pre-
Chief, Infectious Diseases Section, MedStar Washington Hospital clinical Studies Core, Galveston National Laboratory, University of
Center, Washington, DC; Professor of Medicine, Infectious Diseases, Texas Medical Branch, Galveston, Texas
Uniformed Services University of the Health Sciences, F. Edward Lymphocytic Choriomeningitis, Lassa Fever, and the South Ameri-
Hebert School of Medicine, Bethesda, Maryland can Hemorrhagic Fevers (Arenaviruses)
Drugs for Protozoal Infections Other Than Malaria
Werner Zimmerli, MD
William F. Wright, DO, MPH Professor, Basel University Medical Clinic, Liestal, Switzerland
Assistant Professor of Medicine and Microbiology, Division of Infec- Orthopedic Implant–Associated Infections
tious Diseases and Travel Medicine, Georgetown University School
of Medicine, Washington, DC Stephen H. Zinner, MD
Fever of Unknown Origin Charles S. Davidson Professor of Medicine, Harvard Medical School,
Boston, Massachusetts; Chair, Department of Medicine, Mount
Jo-Anne H. Young, MD Auburn Hospital, Cambridge, Massachusetts
Professor of Medicine, Division of Infectious Disease and International Sulfonamides and Trimethoprim
Medicine, Medical Director of the Program in Adult Transplant
Infectious Disease University of Minnesota, Minneapolis, Minne- John J. Zurlo, MD
sota; Editor-in-Chief, Clinical Microbiology Reviews, American Professor of Medicine, Department of Medicine/Infectious Diseases,
Society of Microbiology, Washington, DC Penn State Hershey Medical Center, Hershey, Pennsylvania
Infections in Recipients of Hematopoietic Stem Cell Transplants Pasteurella Species